WILL CI­PLA IN­DIA UP THE ANTE?

Finweek English Edition - - INVESTMENT -

Ci­pla Med­pro has the in­dica­tive of­fer of 855c from Ci­pla In­dia on the ta­ble but is trad­ing above the 855c level, sug­gest­ing share­hold­ers value the com­pany higher. Ci­pla In­dia will likely still get a fair slice of stock at 855c as there isn’t enough in the mar­ket for large sellers to take ad­van­tage of the higher price. But it does make the point that Ci­pla Med­pro with a con­trol­ling share­holder in Ci­pla In­dia is a more valu­able com­pany, and if I were a holder I would not sell at 855c.

Newspapers in English

Newspapers from South Africa

© PressReader. All rights reserved.